Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 | Bismuth subsalicylate (Pepto Bismol®) | ||
 | Esomeprazole injection | Hospital use only | |
| Famotidine | ||
| Heliobacter stool antigen test | In line with NICE/PHE guidance. Check availability of test in local laboratory. | |
| Heliobacter urea breath test | In line with NICE/PHE guidance. | |
| Lansoprazole | ||
| Lansoprazole orodispersible tablets | Second line - for use in swallowing difficulties or via nasogastric tubes. | |
 | Misoprostol (Cytotec®) | Specialist initiation only - promoting healing of gastric and duodenal ulcers | |
| Nizatidine | ||
| Omeprazole capsules | ||
| Omeprazole IV | Hospital use only | |
| Omeprazole orodispersible tablets | Second line - for use in swallowing difficulties or via nasogastric tubes. | |
| Sucralfate suspension and tablets |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
